Compare Riot Platforms Inc (RIOT) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Riot Platforms Inc vs BIO-TECHNE Corp — how do they compare? Riot Platforms Inc trades at $17.2 (market cap $6.96B), while BIO-TECHNE Corp trades at $72.46 (market cap $11.37B). The key difference: BIO-TECHNE Corp is the larger of the two by market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Riot Platforms Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Riot Platforms Inc for 16 Days and BIO-TECHNE Corp for 63 Days on average.
| RIOT | TECH | |
|---|---|---|
Market Cap | $6.96B | $11.37B |
Volume | 16,308,581 | 3,153,511 |
Sector | Financials | Health |
52-Week High | $28.67 | $72.61 |
52-Week Low | $11.83 | $43.31 |
Typical Hold Time | 16 Days | 63 Days |
Enterprise Value | $7.36B | $11.40B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RIOT trades at $18.54, down 2.06% on the day, with a bearish technical signal despite oscillators showing some buying interest. The company reported significant losses with a net income margin of -196.28% in 2026, though revenue grew to $675 million. Recent news highlights RIOT's strategic pivot to data center services, securing $9.8 billion in contracted lease revenue through 2048 with major tenants including AMD.
Wall Street remains overwhelmingly bullish with 94.74% buy ratings and a $31.64 consensus price target, representing 71% upside. However, persistent negative earnings, high cash burn, and execution risks in the AI infrastructure transition pose substantial challenges for near-term profitability and shareholder value.
TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.
Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
